Patents by Inventor Gilbert A. Block

Gilbert A. Block has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATMENT OF MACROPHAGE-RELATED DISORDERS
    Publication number: 20170106017
    Abstract: Provided herein are methods and composition for the treatment for macrophage-related disorders, for example through the use of biomarkers for selection of responders and treatment monitoring.
    Type: Application
    Filed: May 15, 2015
    Publication date: April 20, 2017
    Inventors: Michael S. McGRATH, Gilbert BLOCK
  • Treatment of Psychoses with Dibenzothiazepine Antipsychotic
    Publication number: 20100311718
    Abstract: The present invention provides methods for treating depression symptoms associated with bipolar disorder.
    Type: Application
    Filed: August 17, 2010
    Publication date: December 9, 2010
    Applicant: AstraZeneca AB
    Inventors: Brian Ault, Gilbert Block, Martin Brecher, Wayne MacFadden, Robin McCoy, Margaret Minkwitz, Jamie Mullen, Ellis Wilson
  • Treatment of psychoses with dibenzothiazepine antipsychotic
    Publication number: 20050171088
    Abstract: The present invention provides methods for treating depression symptoms associated with bipolar disorder.
    Type: Application
    Filed: January 26, 2005
    Publication date: August 4, 2005
    Inventors: Brian Ault, Gilbert Block, Martin Brecher, Wayne MacFadden, Robin McCoy, Margaret Minkwitz, Jamie Mullen, Ellis Wilson
  • Method of treating neurodegenerative diseases
    Patent number: 6531488
    Abstract: The present invention provides a method of treating a neurodegenerative disease, and in particular Alzheimer's disease, Mild Cognitive Impairment or other objective memory impairment which comprises the co-administration of ARICEPT or other cholinesterase inhibitor or cholenergic angonist and an effective amount of a selective COX-2 inhibitor. Although a wide range of COX-2 inhibitors may be employed in combination with ARICEPT, there are preferred choices which are specifically set forth herein.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: March 11, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Gilbert A. Block, Per Wold-Olsen
  • Combination of a GABAA alpha 5 inverse agonist and COX-2 inhibitor, NSAID, estrogen or vitamin E
    Patent number: 6440967
    Abstract: Combinations of a GABAA alpha 5 inverse agonist and a COX-2 inhibitor, NSAID, estrogen or vitamin E are disclosed for treating neurodegenerative conditions such as Alzheimer's Disease.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: August 27, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Gilbert A. Block, Christopher R. Lines